Morrish Tammy A, Greider Carol W
Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
PLoS Genet. 2009 Jan;5(1):e1000357. doi: 10.1371/journal.pgen.1000357. Epub 2009 Jan 30.
Human tumors that lack telomerase maintain telomeres by alternative lengthening mechanisms. Tumors can also form in telomerase-deficient mice; however, the genetic mechanism responsible for tumor growth without telomerase is unknown. In yeast, several different recombination pathways maintain telomeres in the absence of telomerase-some result in telomere maintenance with minimal effects on telomere length. To examine non-telomerase mechanisms for telomere maintenance in mammalian cells, we used primary cells and lymphomas from telomerase-deficient mice (mTR-/- and Emumyc+mTR-/-) and CAST/EiJ mouse embryonic fibroblast cells. These cells were analyzed using pq-ratio analysis, telomere length distribution outliers, CO-FISH, Q-FISH, and multicolor FISH to detect subtelomeric recombination. Telomere length was maintained during long-term growth in vivo and in vitro. Long telomeres, characteristic of human ALT cells, were not observed in either late passage or mTR-/- tumor cells; instead, we observed only minimal changes in telomere length. Telomere length variation and subtelomeric recombination were frequent in cells with short telomeres, indicating that length maintenance is due to telomeric recombination. We also detected telomere length changes in primary mTR-/- cells that had short telomeres. Using mouse mTR+/- and human hTERT+/- primary cells with short telomeres, we found frequent length changes indicative of recombination. We conclude that telomere maintenance by non-telomerase mechanisms, including recombination, occurs in primary cells and is initiated by short telomeres, even in the presence of telomerase. Most intriguing, our data indicate that some non-telomerase telomere maintenance mechanisms occur without a significant increase in telomere length.
缺乏端粒酶的人类肿瘤通过替代延长机制维持端粒。端粒酶缺陷型小鼠也能形成肿瘤;然而,在没有端粒酶的情况下肿瘤生长所涉及的遗传机制尚不清楚。在酵母中,几种不同的重组途径在没有端粒酶的情况下维持端粒——有些途径导致端粒维持,对端粒长度影响最小。为了研究哺乳动物细胞中端粒维持的非端粒酶机制,我们使用了来自端粒酶缺陷型小鼠(mTR-/-和Emumyc+mTR-/-)的原代细胞和淋巴瘤以及CAST/EiJ小鼠胚胎成纤维细胞。使用pq比率分析、端粒长度分布异常值、CO-FISH、Q-FISH和多色FISH对这些细胞进行分析,以检测亚端粒重组。在体内和体外长期生长过程中端粒长度得以维持。在传代后期细胞或mTR-/-肿瘤细胞中均未观察到人类ALT细胞特有的长端粒;相反,我们仅观察到端粒长度的微小变化。端粒长度变异和亚端粒重组在端粒较短的细胞中很常见,这表明长度维持是由于端粒重组。我们还在端粒较短的原代mTR-/-细胞中检测到了端粒长度变化。使用端粒较短的小鼠mTR+/-和人类hTERT+/-原代细胞,我们发现频繁的长度变化表明发生了重组。我们得出结论,包括重组在内的非端粒酶机制维持端粒的现象发生在原代细胞中,并且由短端粒引发,即使存在端粒酶也是如此。最有趣的是,我们的数据表明一些非端粒酶端粒维持机制发生时端粒长度没有显著增加。